Status:
UNKNOWN
Evaluation of Anti-neutrophil Cytoplasm Antibodies Test
Lead Sponsor:
Sohag University
Conditions:
Immunological Testing in Small-vessel Vasculitis
Eligibility:
All Genders
18+ years
Brief Summary
Anti-neutrophil cytoplasm antibodies (ANCA) are defined as important serological markers for the diagnosis of some forms of small vessel vasculitis, including granulomatosis with polyangiitis (GPA) , ...
Detailed Description
To evaluate the performance of the recommended strategy for the detection of ANCA based on screening with antigen specific immunoassays on a number of AAV patients and relevant disease controls (i. e....
Eligibility Criteria
Inclusion
- .All patients included must be older than 18 years and able to give informed consent.
- Classification criteria and nomenclature for AAV are from the American College of Rheumatology
- Serum sampling should be done before initiation of immunosuppressive treatment or no later than 2 weeks after onset of low-medium dose of immunosuppressive treatment (but this should be documented)
Exclusion
- .Patients younger than 18 years old
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04719715
Start Date
February 1 2021
End Date
February 1 2023
Last Update
January 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kagawa univeristy
Hiragi, Kagawa-ken, Japan, 761-0793